Key facts
- This page summarizes George P. Denny III's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2024, 19:14.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Purchase
Additional SEC filing notes
Footnote F1
Denny Family Partners II, LLC ("DFP") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
Footnote F2
The reporting person disclaims beneficial ownership of the securities held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein.